Can Amyvid Be An Important Alzheimer's Product Without An Alzheimer's Indication?

Members of the FDA advisory committee that reviewed Avid Radiopharmaceuticals' Amyvid appear less enthusiastic about the product's immediate prospects than the firm itself, but actually could be more enthusiastic about the diagnostic's long-term utility than even the sponsor.